The Allstate Corporation (ALL)
Valuation Overview•Is The Allstate Corporation Overvalued or Undervalued?
Trading at a discount across both intrinsic cash flow and relative peer multiples, indicating a strong margin of safety.
High-quality fundamentals with a strong composite quality score of 76/100, backed by robust profitability and solvency.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Verdict: Solid fundamental quality, though profitability presents a headwind.
Wall Street is broadly bullish, projecting solid upside. This is paired with healthy capital returns, driven by a balanced mix of reliable dividends and share buybacks.
ALL demonstrates strong business quality with robust profitability and healthy margins (highlighted by a massive 29.8% ROIC). This is paired with a moderately leveraged but stable balance sheet.
The company demonstrates solid revenue growth (9.5% 3Y CAGR) paired with stable bottom-line earnings. The company maintains healthy operational efficiency with a 23.3% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $16.9B | +4.6% | +9.5% | +9.8% | +6.4% | |
| EBITDA | $3.3B | — | — | — | — | |
| Net Income | $2.5B | +120.3% | — | — | +16.8% | |
| EPS (Diluted) | $9.25 | +124.8% | — | +17.1% | +22.4% | |
| Free Cash Flow | $3.5B | +13.3% | +28.1% | +13.8% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 39.8% | 22.9% | 20.9% | 23.3% |
| Operating Margin | 23.3% | 9.4% | 7.6% | 9.3% |
| Net Margin | 18.1% | 7.5% | 4.7% | 6.8% |
| FCF Margin | 17.2% | 11.9% | 10.9% | 11.1% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $7.31 | $10.65 | +45.7% | ||
| Q1'26 | $9.83 | $14.31 | +45.6% | ||
| Q4'25 | $7.67 | $11.17 | +45.6% | ||
| Q3'25 | $3.25 | $5.94 | +82.8% | ||
| Q2'25 | $2.52 | $3.53 | +40.1% | ||
| Q1'25 | $5.40 | $7.67 | +42.0% | ||
| Q4'24 | $2.36 | $3.91 | +65.7% | ||
| Q3'24 | $0.28 | $1.61 | +478.3% |
Total return is +15.2% (1Y), lagging the benchmark by -9.8%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +9.6% | +0.3% | — |
| 1Y | +15.2% | -9.8% | +2.1% |
| 3YCAGR | +28.9% | +9.5% | +10.7% |
| 5YCAGR | +14.1% | +1.2% | +14.8% |
| 10YCAGR | +14.1% | +0.5% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about The Allstate Corporation (ALL) valuation, health, and returns.
The Allstate Corporation is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Cheap versus peers compared to industry peers. undervalued (implying +45.2% upside to DCF intrinsic value of $321.09)
The Allstate Corporation has multiple valuation anchors: DCF Intrinsic Value: $321.09 | Peer Relative Fair Value: $391.58 | Wall Street Analyst Target: $250.00 (implying +13.0% upside). A convergence of these signals offers higher conviction.
The Allstate Corporation displays good financial health with a composite quality score of 76/100, supported by a Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 29.8%.
The Allstate Corporation pays a 1.8% dividend yield, covered by a 10% payout ratio with 15 years of growth, supplemented by a 2.2% buyback yield.
The Allstate Corporation's current growth trajectory is Decelerating. The company achieved +4.6% 1Y revenue growth and +124.8% 1Y EPS growth, compared to its 3Y revenue CAGR of +9.5%.
Wall Street consensus is Hold based on 44 analysts, beating EPS expectations in 92% of recent quarters with a 11-quarter streak. The consensus price target represents a +13.0% change from current levels.
Investment risks for The Allstate Corporation include: -11.5% 1-year max drawdown. Volatility risk is characterized by a beta of -0.12x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.